Comparison

PROTAC PTPN2 degrader-1 European Partner

Item no. HY-148691-50mg
Manufacturer MedChem Express
CASRN 2655638-07-4
Amount 50 mg
Quantity options 10 mg 1 ea 1 mg 25 mg 50 mg 5 mg
Specific against other
Purity 95.01
Citations [1]Gesine Kerstin Veits, et al. Protein tyrosine phosphatase degraders and methods of use thereof. WO2021127586A1.
Smiles O=C(CC1=CC=C(C2=CC(N(C)C(N3C4C(NC(CC4)=O)=O)=O)=C3C=C2)C=C1)NC5=CC6=CC(O)=C(N7CC(NS7(=O)=O)=O)C(F)=C6C=C5
Available
Product Description
PROTAC PTPN2 degrader-1 (compound example 77) is a potent PTPN2 degrader. PROTAC PTPN2 degrader-1 has the potential for the research of cancer or metabolic disease[1].
StorageTemperature
4°C (Powder, protect from light, stored under nitrogen)
Shipping
Room Temperature
Manufacturers Applications
Metabolism-sugar/lipid metabolism
MolecularWeight
686.67
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer; Metabolic Disease
Solubility
DMSO : 100 mg/mL (ultrasonic)
Target
Phosphatase; PROTACs
Manufacturers Target
Phosphatase; PROTACs
Manufacturers Pathway
Metabolic Enzyme/Protease; PROTAC
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close